Novateor Research Laboratories Limited

BSE:542771 Stock Report

Market Cap: ₹247.8m

Novateor Research Laboratories Valuation

Is 542771 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 542771 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 542771's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 542771's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 542771?

Key metric: As 542771 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 542771. This is calculated by dividing 542771's market cap by their current revenue.
What is 542771's PS Ratio?
PS Ratio15.1x
Sales₹16.38m
Market Cap₹247.75m

Price to Sales Ratio vs Peers

How does 542771's PS Ratio compare to its peers?

The above table shows the PS ratio for 542771 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.9x
507970 Paramount Cosmetics (India)
1.2xn/a₹241.1m
542248 Deccan Health Care
0.9xn/a₹572.2m
531762 Unjha Formulations
0.7xn/a₹124.0m
WALPAR Walpar Nutritions
0.7xn/a₹428.2m
542771 Novateor Research Laboratories
15.1xn/a₹247.8m

Price-To-Sales vs Peers: 542771 is expensive based on its Price-To-Sales Ratio (15.1x) compared to the peer average (0.9x).


Price to Sales Ratio vs Industry

How does 542771's PS Ratio compare vs other companies in the IN Personal Products Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
530689 Lykis
0.2xn/aUS$9.78m
542248 Deccan Health Care
0.9xn/aUS$6.78m
524703 Sandu Pharmaceuticals
0.8xn/aUS$6.50m
WALPAR Walpar Nutritions
0.7xn/aUS$5.07m
542771 15.1xIndustry Avg. 6.7xNo. of Companies5PS048121620+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 542771 is expensive based on its Price-To-Sales Ratio (15.1x) compared to the Indian Personal Products industry average (6.7x).


Price to Sales Ratio vs Fair Ratio

What is 542771's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

542771 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio15.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 542771's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies